[1] |
周泽文, 刘颖春, 向邦德, 等. 原发性肝癌的全球展望:流行情况、危险因素和人群归因分值[J]. 中国癌症防治杂志, 2021, 13(1):14-21.
|
[2] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
DOI
URL
|
[3] |
CHEN B Y, SUNG C W, CHEN C, et al. Advances in exosomes technology[J]. Clin Chim Acta, 2019, 493:14-19.
DOI
URL
|
[4] |
HAYASHI M, YAMADA S, KURIMOTO K, et al. MiR-23b-3p plays an oncogenic role in hepatocellular carcinoma[J]. Ann Surg Oncol, 2021, 28(6):3416-3426.
DOI
PMID
|
[5] |
MANGANELLI M, GROSSI I, FERRACIN M, et al. Longitudinal circulating levels of miR-23b-3p,miR-126-3p and lncRNA GAS5 in HCC patients treated with sorafenib[J]. Biomedicines, 2021, 9(7):813.
DOI
URL
|
[6] |
王攀, 莫经刚, 朱杰, 等. 微滴数字PCR检测血清miR-21和miR-4429在肝癌诊断中的应用[J]. 浙江医学, 2017, 39(3):170-172.
|
[7] |
中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版)[J]. 临床肝胆病杂志, 2011, 27(11):1141-1159.
|
[8] |
中华医学会感染病学分会,中华医学会肝病学分析. 慢性乙型肝炎防治指南(2019年版)[J]. 肝脏, 2019, 24(12):1335-1356.
|
[9] |
ZHU J, ZHENG Z, WANG J, et al. Different miRNA expression profiles between human breast cancer tumors and serum[J]. Front Genet, 2014, 5:149.
DOI
PMID
|
[10] |
DEMORY BECKLER M, HIGGINBOTHAM J N, FRANKLIN J L, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS[J]. Mol Cell Proteomics, 2013, 12(2):343-355.
DOI
PMID
|
[11] |
WHITESIDE T L. Tumor-derived exosomes and their role in cancer progression[J]. Adv Clin Chem, 2016, 74:103-141.
DOI
PMID
|
[12] |
FANG T, LV H, LV G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J]. Nat Commun, 2018, 9(1):191.
DOI
PMID
|
[13] |
WANG H, HOU L, LI A, et al. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma[J]. Biomed Res Int, 2014, 2014:864894.
|
[14] |
SOHN W, KIM J, KANG S H, et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma[J]. Exp Mol Med, 2015, 47(9):e184.
DOI
|
[15] |
SUN Q, LI J, JIN B, et al. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage[J]. Clin Res Hepatol Gastroenterol, 2020, 44(1):21-28.
DOI
URL
|
[16] |
WANG J, XUE H, ZHU Z, et al. Expression of serum exosomal miR-23b-3p in non-small cell lung cancer and its diagnostic efficacy[J]. Oncol Lett, 2020, 20(4):30.
DOI
PMID
|